Condensed Consolidated Statements of Stockholders’ (Deficit) Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2024		$ 2	$ 192,305,280	$ (193,353,198)	$ (1,047,916)
Balance (in Shares) at Dec. 31, 2024		199,110
Reclassification of Series A warrants to equity			7,634,427		7,634,427
Exercise of Series B warrants in connection with the public offering		$ 16	18,931,781		18,931,797
Exercise of Series B warrants in connection with the public offering (in Shares)		1,552,796
Stock-based compensation			536,244		536,244
Net loss				(3,911,647)	(3,911,647)
Balance at Mar. 31, 2025		$ 18	219,407,732	(197,264,845)	22,142,905
Balance (in Shares) at Mar. 31, 2025		1,751,906
Balance at Dec. 31, 2025		$ 80	255,576,797	(216,822,471)	38,754,406
Balance (in Shares) at Dec. 31, 2025		7,974,380
Issuance of at-the-market common stock, net of issuance costs		$ 39	9,166,388		9,166,427
Issuance of at-the-market common stock, net of issuance costs (in Shares)		3,922,113
Issuance of common stock in connection with the public offering		$ 17	8,749,450		8,749,467
Issuance of common stock in connection with the public offering (in Shares)		1,711,788
Stock-based compensation			386,289		386,289
Net loss				(6,486,759)	(6,486,759)
Balance at Mar. 31, 2026		$ 136	$ 273,878,924	$ (223,309,230)	$ 50,569,830
Balance (in Shares) at Mar. 31, 2026		13,608,281